Oppenheimer Asset Management’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-23,260
| Closed | -$219K | – | 1150 |
|
|
2024
Q4 | $219K | Sell |
23,260
-9,740
| -30% | -$91.8K | ﹤0.01% | 1060 |
|
|
2024
Q3 | $352K | Sell |
33,000
-18,352
| -36% | -$196K | ﹤0.01% | 955 |
|
|
2024
Q2 | $509K | Buy |
51,352
+11
| +0% | +$109 | 0.01% | 856 |
|
|
2024
Q1 | $605K | Buy |
51,341
+158
| +0.3% | +$1.86K | 0.01% | 791 |
|
|
2023
Q4 | $726K | Sell |
51,183
-7,863
| -13% | -$112K | 0.01% | 779 |
|
|
2023
Q3 | $718K | Sell |
59,046
-200
| -0.3% | -$2.43K | 0.01% | 767 |
|
|
2023
Q2 | $744K | Sell |
59,246
-3,368
| -5% | -$42.3K | 0.01% | 764 |
|
|
2023
Q1 | $694K | Sell |
62,614
-4,464
| -7% | -$49.5K | 0.01% | 767 |
|
|
2022
Q4 | $819K | Buy |
67,078
+12,206
| +22% | +$149K | 0.01% | 724 |
|
|
2022
Q3 | $573K | Sell |
54,872
-2,151
| -4% | -$22.5K | 0.01% | 798 |
|
|
2022
Q2 | $612K | Sell |
57,023
-3,111
| -5% | -$33.4K | 0.01% | 803 |
|
|
2022
Q1 | $569K | Buy |
60,134
+5,265
| +10% | +$49.8K | 0.01% | 888 |
|
|
2021
Q4 | $634K | Buy |
54,869
+11,817
| +27% | +$137K | 0.01% | 903 |
|
|
2021
Q3 | $411K | Sell |
43,052
-2,653
| -6% | -$25.3K | 0.01% | 978 |
|
|
2021
Q2 | $441K | Sell |
45,705
-797
| -2% | -$7.69K | 0.01% | 989 |
|
|
2021
Q1 | $459K | Buy |
+46,502
| New | +$459K | 0.01% | 933 |
|